TELA Bio, Inc. (TELA) Tops Q3 EPS by 3c

TELA Bio, Inc. (NASDAQ: TELA) reported Q3 EPS of ($0.45), $0.03 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $15.1 million versus the consensus estimate of $16.2 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Goldman Sachs Double Upgrades Bradsaude SA (SAUD3:BZ) to Buy
• Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules